Submitted by Sheldon Rampton on
The Center for Science in the Public Interest is criticizing the Providence Journal for publishing an op-ed article by Robert Goldberg while failing to disclose that Goldberg and his organization, the Center for Medicine in the Public Interest
Submitted by Sheldon Rampton on
The pharmaceutical industry is using a novel technique to cheer up people who suffer from clinical depression -- only publishing favorable studies about the effects of its antidepressant medications.
Submitted by Anne Landman on
Capitalizing on the public's familiarity with cigarette brands, a publisher and design company in the United Kingdom has released a set of literary classics designed to look like cigarette packs.
Submitted by Diane Farsetta on
"I could not with a clear conscience go into that newsroom and tell the staff that this was a good thing," explained former WEAU-13 news director Glen Mabie. Mabie resigned from the northwest Wisconsin television station "because of a disagreement ...
A recent report issued by the American Lung Association gives the State of Virginia a "D" for its youth smoking prevention efforts.
Submitted by Diane Farsetta on
"Fibromyalgia is a real, widespread pain condition," stresses a woman in a television ad for Lyrica, a Pfizer drug that recently became "the first medicine approved to treat the pain condition." But some doctors have their doubts. These skeptics "say vague complaints of chronic pain do not add up to a disease. ... The condition cannot be linked to any environmental or biological causes." Even Dr.
Submitted by Diane Farsetta on
The U.S. Congress is investigating "the pharmaceutical industry's use of celebrity endorsements in direct-to-consumer (DTC) advertisements." First up are ads for Pfizer's cholesterol drug Lipitor, which feature the inventor of the artificial heart, Dr. Robert Jarvik.
Submitted by Anne Landman on
Australia's 1992 Tobacco Advertising Prohibition Act prohibited most forms of tobacco advertising, making it more difficult for tobacco companies to promote their products. Despite the law, an Australian market-research firm called Feedback Plus was found to be distributing free cigarettes in a program it said was a "taste-testing survey" being carried out as part of a "marketing research" program.
Submitted by Judith Siers-Poisson on
The pharmaceutical industry often uses the need for research and development funds as an excuse for exorbitant drug prices. But a new study by Marc-Andre Gagnon and Dr.
Center for Media and Democracy (CMD)
520 University Ave, Ste 305 • Madison, WI 53703 • (608) 260-9713
CMD is a 501(c)(3) tax-exempt non-profit.
© 1993-2025